Oakley Prescriptions Limited
11183748
Some Concerns
- Current liabilities exceed current assets (-10)
- 3 outstanding charges (-6)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 29/08/2024
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 40
Also on 3 other boards
Persons with Significant Control
B & P Pharma Limited
167, Uxbridge Road, London, W7 3TH
Reg: 14544024 · Uk Companies Registration Office · Limited Company
Notified 29/08/2024
Former PSCs
Mr Benjamin Tuffour
Ceased 18/05/2018
Tuffour Pharm Group Limited
Ceased 29/08/2024
Charges3 outstanding
TSB BANK PLC
TSB BANK PLC
TSB BANK PLC
RX BRIDGE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
CompanyRankvs 3167+ SIC 47730 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£18k
Balance sheet strength
Cash
£12k
Cash in the bank
Net Current Assets
-£132k
Working capital
Current Assets
£285k
Current Liabilities
£417k
Fixed Assets
£302k
Debtors
£234k
Tax at Year End(2022)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.68 | -£7k |
| 2024 | 0.69 | -£122k |
| 2023 | 1.49 | — |
| 2022 | 1.03 | — |
| 2021 | 1.50 | — |
Derived from filed accounts. Not audited figures.